| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mani N Pavuluri, David B Henry, Julie A Carbray, Gwendolyn Sampson, Michael W Naylor, Philip G Janica. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. Journal of affective disorders. vol 82 Suppl 1. 2005-03-15. PMID:15571784. |
this prospective 6-month open trial examined the safety and efficacy of two combination therapies for manic or mixed episodes of pediatric bipolar disorder: (1) divalproex sodium plus risperidone (dvpx+risp), or (2) lithium plus risperidone (li+risp). |
2005-03-15 |
2023-08-12 |
Not clear |
| Richard C Shelton, Stephen M Stah. Risperidone and paroxetine given singly and in combination for bipolar depression. The Journal of clinical psychiatry. vol 65. issue 12. 2005-02-07. PMID:15641878. |
the current study was intended to evaluate the effects of the novel antipsychotic risperidone, the selective serotonin reup-take inhibitor (ssri) paroxetine, and the combination in patients with bipolar disorder. |
2005-02-07 |
2023-08-12 |
Not clear |
| Won-Myong Bahk, Jin-Sang Yoon, Young-Hoon Kim, Yang-Hyun Lee, Chul Lee, Kwang-Soo Kim, Hye-Kyoung Song, Sung-Ku Choi, Chi-Un Pa. Risperidone in combination with mood stabilizers for acute mania: a multicentre, open study. International clinical psychopharmacology. vol 19. issue 5. 2004-12-02. PMID:15289703. |
the present larger open study indicates that risperidone add-on therapy is effective and tolerable in treatment of bipolar disorder, replicating results in various controlled and uncontrolled studies from western countries. |
2004-12-02 |
2023-08-12 |
Not clear |
| S Nassir Ghaemi, Douglas J Hsu, Klara J Rosenquist, Jacob J Katzow, Frederick K Goodwi. Long-term observational comparison of risperidone and olanzapine in bipolar disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 16. issue 2. 2004-10-19. PMID:15328900. |
long-term observational comparison of risperidone and olanzapine in bipolar disorder. |
2004-10-19 |
2023-08-12 |
Not clear |
| S Nassir Ghaemi, Douglas J Hsu, Klara J Rosenquist, Jacob J Katzow, Frederick K Goodwi. Long-term observational comparison of risperidone and olanzapine in bipolar disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 16. issue 2. 2004-10-19. PMID:15328900. |
to compare long-term effectiveness and safety of risperidone versus olanzapine as adjunctive maintenance treatments of bipolar disorder. |
2004-10-19 |
2023-08-12 |
Not clear |
| S Nassir Ghaemi, Douglas J Hsu, Klara J Rosenquist, Jacob J Katzow, Frederick K Goodwi. Long-term observational comparison of risperidone and olanzapine in bipolar disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 16. issue 2. 2004-10-19. PMID:15328900. |
risperidone and olanzapine appeared to have similar real-world maintenance effectiveness for bipolar disorder, but differed somewhat in side effects. |
2004-10-19 |
2023-08-12 |
Not clear |
| Arun Ravindran, Peter Silverstone, Denis Lacroix, Erno van Schaick, An Vermeulen, Jennifer Alexande. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder. Clinical pharmacokinetics. vol 43. issue 11. 2004-09-28. PMID:15301577. |
risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder. |
2004-09-28 |
2023-08-12 |
human |
| Arun Ravindran, Peter Silverstone, Denis Lacroix, Erno van Schaick, An Vermeulen, Jennifer Alexande. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder. Clinical pharmacokinetics. vol 43. issue 11. 2004-09-28. PMID:15301577. |
the combination of risperidone and divalproex sodium is used to treat the manic phase of bipolar disorder. |
2004-09-28 |
2023-08-12 |
human |
| Prakash S Masa. Atypical antipsychotics in the treatment of affective symptoms: a review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 16. issue 1. 2004-08-10. PMID:15147108. |
this review focuses on risperidone, olanzapine, quetiapine, and ziprasidone and provides evidence that these drugs demonstrate activity against manic episodes of bipolar disorder when used as adjunctive therapy and possibly as monotherapy and that depression in patients with schizoaffective disorder also responds to these agents. |
2004-08-10 |
2023-08-12 |
Not clear |
| Charles L Bowden, Joyce E Myers, Fred Grossman, Yang Xi. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder. The Journal of clinical psychiatry. vol 65. issue 5. 2004-06-28. PMID:15163260. |
combination therapy (risperidone and a mood stabilizer) for patients with a history of bipolar disorder (dsm-iv) and hospitalized for treatment of a manic episode was assessed in a 13-week study. |
2004-06-28 |
2023-08-12 |
Not clear |
| Lakshmi N Yatham, Carin Binder, Vivek Kusumakar, Rosanna Riccardell. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076019. |
this exploratory analysis was performed to compare the efficacy and tolerability of risperidone when added to two different mood stabilizers (lithium or valproate) for mania in bipolar disorder. |
2004-06-22 |
2023-08-12 |
Not clear |
| Gary S Sach. Unmet clinical needs in bipolar disorder. Journal of clinical psychopharmacology. vol 23. issue 3 Suppl 1. 2003-10-21. PMID:12832943. |
recently, atypical antipsychotics, such as olanzapine, risperidone, and quetiapine, have been evaluated for the treatment of bipolar disorder. |
2003-10-21 |
2023-08-12 |
Not clear |
| Lakshmi N Yatha. Mood stabilization and the role of antipsychotics. International clinical psychopharmacology. vol 17 Suppl 3. 2003-02-25. PMID:12570068. |
this article will review the results from open and double-blind studies with quetiapine, ziprasidone, risperidone and olanzapine in the management of bipolar disorder. |
2003-02-25 |
2023-08-12 |
Not clear |
| Eduard Vieta, Marisa Herraiz, Gemma Parramon, J M Goikolea, Antonio Fernández, Antoni Benabarr. Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain. Journal of affective disorders. vol 72. issue 1. 2002-10-28. PMID:12204313. |
a number of open studies and preliminary results of unpublished double-blind trials have suggested that the novel antipsychotic risperidone may be effective and well tolerated in the treatment of acute mania in bipolar disorder. |
2002-10-28 |
2023-08-12 |
Not clear |
| Steven G Potkin, Per T Thyrum, Gustavo Alva, Rimal Bera, Chiao Yeh, Lisa A Arvaniti. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. Journal of clinical psychopharmacology. vol 22. issue 2. 2002-05-13. PMID:11910256. |
the effects of haloperidol, risperidone, and thioridazine on the pharmacokinetics and side-effect profile of quetiapine were investigated in 36 patients with schizophrenia, schizoaffective disorder, or bipolar disorder in a single-center, two-period, multiple-dose, open-label, randomized trial. |
2002-05-13 |
2023-08-12 |
Not clear |
| S N Ghaem. New treatments for bipolar disorder: the role of atypical neuroleptic agents. The Journal of clinical psychiatry. vol 61 Suppl 14. 2001-02-15. PMID:11154015. |
currently, a number of prospective studies are available with clozapine, risperidone, olanzapine, and quetiapine in the treatment of bipolar disorder. |
2001-02-15 |
2023-08-12 |
Not clear |
| C Guille, G S Sachs, S N Ghaem. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. The Journal of clinical psychiatry. vol 61. issue 9. 2000-10-25. PMID:11030483. |
a naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. |
2000-10-25 |
2023-08-12 |
Not clear |
| K G Rottach, J Weiss-Brummer, U Wieland, M Schmaus. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy]. Der Nervenarzt. vol 71. issue 5. 2000-07-14. PMID:10846716. |
a 28-year-old patient with a 5-year history of bipolar disorder developed signs of encephalopathy 2 weeks after the addition of valproic acid to his treatment regimen of doxepine, risperidone, and biperidene. |
2000-07-14 |
2023-08-12 |
Not clear |
| J A Frazier, M C Meyer, J Biederman, J Wozniak, T E Wilens, T J Spencer, G S Kim, S Shapir. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. Journal of the American Academy of Child and Adolescent Psychiatry. vol 38. issue 8. 1999-08-17. PMID:10434487. |
risperidone treatment for juvenile bipolar disorder: a retrospective chart review. |
1999-08-17 |
2023-08-12 |
Not clear |
| H A Schreie. Risperidone for young children with mood disorders and aggressive behavior. Journal of child and adolescent psychopharmacology. vol 8. issue 1. 1998-09-16. PMID:9639079. |
open clinical treatment with risperidone was administered to a clinically heterogeneous group of 11 children and adolescents (age range 5.5-16 years, mean 9.8 years) with concurrent presentation of affective symptoms (mostly suggestive of bipolar disorder), aggressive and violent behavior, and marked management problems. |
1998-09-16 |
2023-08-12 |
Not clear |